265 related articles for article (PubMed ID: 1747111)
1. Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver.
Cannon JR; Eacho PI
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):387-91. PubMed ID: 1747111
[TBL] [Abstract][Full Text] [Related]
2. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
[TBL] [Abstract][Full Text] [Related]
3. Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus.
Lawrence JW; Kroll DJ; Eacho PI
J Lipid Res; 2000 Sep; 41(9):1390-401. PubMed ID: 10974046
[TBL] [Abstract][Full Text] [Related]
4. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
[TBL] [Abstract][Full Text] [Related]
5. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Foxworthy PS; White SL; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
7. Concomitant increase by peroxisome proliferators of fatty acid-binding protein, peroxisomal beta-oxidation and cytosolic acyl-CoA hydrolase in liver.
Katoh H; Kawashima Y; Takegishi M; Watanuki H; Hirose A; Kozuka H
Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):229-41. PubMed ID: 2865776
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
9. Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver.
Wolfrum C; Börchers T; Sacchettini JC; Spener F
Biochemistry; 2000 Feb; 39(6):1469-74. PubMed ID: 10684629
[TBL] [Abstract][Full Text] [Related]
10. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake.
Wolfrum C; Buhlmann C; Rolf B; Börchers T; Spener F
Biochim Biophys Acta; 1999 Feb; 1437(2):194-201. PubMed ID: 10064902
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic level of fatty-acid-binding protein by hormones and clofibric acid in the rat.
Nakagawa S; Kawashima Y; Hirose A; Kozuka H
Biochem J; 1994 Feb; 297 ( Pt 3)(Pt 3):581-4. PubMed ID: 8110197
[TBL] [Abstract][Full Text] [Related]
12. Effect of the peroxisome proliferator LY171883 on triglyceride accumulation in rats fed a fat-free diet.
Foxworthy PS; Eacho PI
Biochem Pharmacol; 1991 Sep; 42(7):1487-91. PubMed ID: 1930273
[TBL] [Abstract][Full Text] [Related]
13. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.
Khan SH; Sorof S
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):848-52. PubMed ID: 8302856
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
Moya-Camarena SY; Van den Heuvel JP; Belury MA
Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
[TBL] [Abstract][Full Text] [Related]
15. Effects of peroxisome proliferators on fatty acid-binding protein in rat liver.
Kawashima Y; Nakagawa S; Tachibana Y; Kozuka H
Biochim Biophys Acta; 1983 Nov; 754(1):21-7. PubMed ID: 6626564
[TBL] [Abstract][Full Text] [Related]
16. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
17. Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883.
Foxworthy PS; Perry DN; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Dec; 106(3):375-83. PubMed ID: 1979695
[TBL] [Abstract][Full Text] [Related]
18. Effects of some hypolipidemic drugs and phthalic acid esters on fatty acid binding protein in rat liver.
Kawashima Y; Nakagawa S; Kozuka H
J Pharmacobiodyn; 1982 Oct; 5(10):771-9. PubMed ID: 7161705
[TBL] [Abstract][Full Text] [Related]
19. The effects of peroxisome proliferators on protein abundances in mouse liver.
Anderson NL; Esquer-Blasco R; Richardson F; Foxworthy P; Eacho P
Toxicol Appl Pharmacol; 1996 Mar; 137(1):75-89. PubMed ID: 8607144
[TBL] [Abstract][Full Text] [Related]
20. Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein.
Raza H; Pongubala JR; Sorof S
Biochem Biophys Res Commun; 1989 Jun; 161(2):448-55. PubMed ID: 2500117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
